Putting out a crappy PR before Friday market open instead of Friday market close didn't help today. NP better drop a PR that blows the doors off next week. Without news of revenue, we're not breaking above $3.50 anytime soon.
Even saving the life of another country's beloved ex-Pres did absolutely nothing for the share price. Where are all the South Asian retail investors just now learning about Leronlimab?